study question: What is the optimal stage from oocyte through preimplantation embryo development for biopsy and preimplantation genetic screening (PGS) to detect abnormal chromosome segregation patterns in eggs or embryos from advanced maternal age (AMA) patients? summary answer: Testing at the polar body (PB) stage was the least accurate mainly due to the high incidence of post-zygotic events.
study question: What is the optimal stage from oocyte through preimplantation embryo development for biopsy and preimplantation genetic screening (PGS) to detect abnormal chromosome segregation patterns in eggs or embryos from advanced maternal age (AMA) patients? summary answer: Testing at the polar body (PB) stage was the least accurate mainly due to the high incidence of post-zygotic events.
This suggests that postponing the time of biopsy to the blastocyst stage of preimplantation embryo development may provide the most reliable results for PGS.
what is known already: In the PGS field there is an ongoing debate about the optimal biopsy stage for PGS. This is a result of the lack of understanding of how aneuploidy arises in the human embryo. To date, most of the cytogenetic data obtained during PGS investigations have been derived through the analysis of cells at isolated points in the preimplantation window, thus potentially missing critical information on chromosomal segregation. Understanding the chromosome segregation patterns during preimplantation development holds the potential to significantly increase the success rates of IVF. In this study, a sequential comprehensive chromosome analysis of both the PBs and the corresponding embryos at both the cleavage and the blastocyst stages is presented. study design, size, duration: This is a prospective longitudinal cohort study performed between October 2009 and August 2011 involving 9 infertile couples and 21 sets of complete comprehensive chromosomal screening data, including PB1, PB2, corresponding blastomeres and trophectoderm (TE) samples.
participants/materials, setting, methods: Infertile couples undergoing IVF cycles with PGS where the female partner was older than 40 years and with a good response to controlled ovarian stimulation (.10 MII oocytes retrieved) were enrolled into the study. The exclusion criteria were (i) patients presenting with abnormal karyotype; (ii) specific ovarian pathologies including polycystic ovary syndrome, endometriosis grade III or higher and premature ovarian failure and (iii) severe male factor infertility (motile sperm count of ,500 000/ml after preparation of a fresh ejaculate). The PBs, blastomere and TE samples were sequentially biopsied and analyzed by array comparative genomic hybridization (aCGH). The analysis of chromosome segregation patterns was performed to infer the origin of aneuploidy and to investigate the diagnostic accuracy of both PB and cleavage-stage PGS strategies.
Introduction
The prevalence of aneuploidy in human embryos provides a likely explanation for the relatively low success and the high abortion rate observed during assisted reproductive treatment cycles in humans (Spandorfer et al., 2004; Menasha et al., 2005) . It is believed that, in most cases, aneuploidy causes embryos to either fail to implant after transfer or spontaneously abort early in gestation (see Macklon et al., 2002) . It has been shown that normal preimplantation embryo development does not correlate with euploidy. Both blastocysts of good and poor morphology have almost the same probability of carrying chromosomal abnormalities (Fragouli et al., 2008; Alfarawati et al., 2011) .
This poor correlation of conventional embryo selection methods and chromosomal complement led to the introduction of preimplantation genetic screening (PGS) as a complementary treatment during IVF cycles to avoid the transfer of aneuploid embryos. It was thought that implementing PGS would improve delivery rates especially for patients with advanced maternal age (AMA). However, even though the premise behind PGS is widely accepted, its benefits with regard to live birth rate per started cycle has not yet been consistently demonstrated Mastenbroek et al., 2011) . Two main reasons have been put forward to explain this: (i) the cytogenetic investigation methods used, such as fluorescence in situ hybridization (FISH), are able to detect only copy number variation of a few chromosomes and have a considerable per chromosome diagnostic error rate when applied on single cells (Munné et al., 2002; Baart et al., 2004; Li et al., 2005; Colls et al., 2007; Magli et al., 2007; Harper and Harton, 2010, b; Gutiérrez-Mateo et al., 2011) ; (ii) the stage of analysis and the cell type used to infer the chromosome copy number of the embryo do not always correlate with the embryo as a whole (Vanneste et al., 2009a) .
The application of comprehensive chromosome screening (CCS) technologies in the field of PGS has revealed that segregation errors occur at a notable frequency even for those chromosomes that normally were not tested by conventional 9-chromosomes FISH (Voullaire et al., 2000; Wells and Delhanty, 2000; Fishel et al., 2010; Treff et al., 2010a,b; Schoolcraft et al., 2010; Fiorentino et al., 2011; Gutiérrez-Mateo et al., 2011; Fiorentino, 2012) . It is thus hypothesized that high-throughput molecular karyotyping methods have to be used to gain the desired diagnostic accuracy.
The second major issue for the outcome of PGS programs relates to the type of cell biopsied. The biopsied sample should be representative of the embryos' chromosomal constitution and viability after transfer. There are different possible sources of genetic material for testing in the preimplantation window in patients undergoing an IVF cycle: (i) the first and second polar bodies (PBs) (PB approach); (ii) one or two cells biopsied from 5-to 10-cell cleavage-stage embryos on Day 3 and (3) several trophoblast cells (usually 5-10) sampled from the blastocyst. Each of these stages presents with specific diagnostic advantages as well as critical limitations that relate to aneuploidy genesis during both meiosis and the preimplantation period of embryo development (Angell, 1991; Hassold and Hunt, 2001; Delhanty, 2005; Vanneste et al., 2009b; Northrop et al., 2010; Handyside et al., 2012; van Echten-Arends et al., 2011) . In the PGS field there is an ongoing debate about the optimal stage for PGS as a consequence of the lack of a complete understanding of the genesis of human embryo aneuploidy. Indeed, most of the cytogenetic data obtained during PGS investigations have been derived through the analysis of cells at isolated points in the preimplantation window, thus potentially missing critical previous or subsequent information on chromosomal segregation. Understanding the chromosome segregation patterns during preimplantation development holds the potential to significantly increase the success rates of IVF.
By sequential biopsy and array comparative genomic hybridization (a-CGH) analysis of both PBs, blastomeres and TE of the same embryo, this study achieved a comprehensive analysis of the chromosomal segregation patterns from female meiosis through to the blastocyst stage of preimplantation embryo development. This sequential chromosome analysis on individual embryos has allowed inference of mechanisms causing errors during meiosis leading to a better understanding of the aetiology of aneuploidy in a population of AMA patients. This approach has also allowed the concordance studies between molecular karyotyping results at three different points of analysis. Moreover, the study design has allowed the direct evaluation of the potential correction mechanisms of meiotic aneuploidies acting later in preimplantation development as well as an unbiased estimation of the incidence of male and post-zygotic-derived errors in preimplantation human embryos.
Materials and Methods

Study design
This is a prospective longitudinal cohort study. Nine infertile couples undergoing IVF cycles with PGS where the female partner was older than 40 years and with a good response to controlled ovarian stimulation (.10 MII oocytes retrieved) were enrolled into the study. The exclusion criteria were (i) patients presenting with abnormal karyotype; (ii) specific ovarian pathologies including polycystic ovary syndrome, endometriosis grade III or higher and premature ovarian failure and (iii) severe male factor infertility (motile sperm count of ,500 000/ml after preparation of a fresh ejaculate).
The PB, blastomere and trophectoderm (TE) samples were sequentially biopsied and processed for CCS. The analysis of chromosome segregation patterns was performed to infer the origin of aneuploidy. Concordance between the sequential biopsies was also analyzed to determine the fate of aneuploid chromosomes in the preimplantation window.
The Institutional Review Board of both the Valle Giulia clinic, from which the couples were recruited, and the GENOMA center approved the study and a written informed consent was obtained from each couple after counselling.
Ovarian stimulation and laboratory procedures
Controlled ovarian stimulation was performed using a GnRH-agonist long protocol as described previously and oocyte collection was performed at 35 h post-hCG administration. Denudation of the oocyte from the cumulus oophorus was performed by a brief exposure to 40 IU/ml hyaluronidase solution in fertilization media (Sage In-Vitro Fertilization, Inc., Trumbull, CT, USA), followed by mechanical removal of all the corona radiata with the use of plastic pipettes of defined diameters (denuding pipette; COOK Ireland Ltd, Limerick, Ireland). The denudation procedure was performed in a controlled (6% CO2 at 378) environment (IncuChamber L-323, Ksystems, Birkerod, Denmark) between 37 and 40 h post-hCG administration. Particular attention was paid to the removal of all adhering cumulus and coronal cells with the aim of avoiding maternal DNA contamination during the amplification steps. MII oocytes were then subjected to ICSI, between 36 and 38 h post-hCG administration, using previously described techniques and instrumentation (Rienzi et al., 1998) . 16 -18 h post-ICSI, oocytes were assessed for the presence of pronuclei. Those displaying two pronuclei and a second PB were cultured further. All embryos were cultured separately in 35 ml microdrops of cleavage medium under mineral oil (Sage) up to Day 3 of embryo development followed by blastocyst medium (Sage) up to Day 5 or 6, in MINC incubators (COOK) (hypoxic atmosphere containing 6% CO 2 at 378). Vitrification of blastocysts on Day 5 or 6 was performed according to Rienzi et al., 2010. 
Biopsy procedures
All the biopsy procedures were performed on the heated stage of a Nikon IX-70 microscope, equipped with micromanipulation tools, in dishes prepared with three droplets of 10 ml of HEPES-buffered medium (Sage) overlaid with pre-equilibrated mineral oil. A diode laser was used to assist the opening of a 10 -20 mm hole in the zona pellucida by 2 -4 laser shots. At all the biopsy stages, an attempt was made to use the initial zona breach to extract the target cells. A PB biopsy was performed sequentially by aspiration with a PB aspiration pipette (Research instruments, Cornwall TR11 4TA, UK). PB1 was biopsied immediately before ICSI and PB2 was biopsied 16-18 h after ICSI, allowing the distinction between the PBs in all cases and avoiding the degradation of the genetic material. Occasionally, a second hole was required for sampling the second PB. A cleavage-stage embryo biopsy was performed on Day 3 of embryo development by blastomere extrusion of one blastomere from embryos reaching at least the six-cell stage as described by Tarín and Handyside, 1993 . The cleavage-stage biopsy was performed in calciummagnesium-free HEPES buffered medium (Sage) using a blastomere aspiration pipette (Research instruments). On Day 5 or 6 of embryo development expanding and expanded blastocysts with or without herniating cells underwent TE biopsy. Five to 10 TE cells were aspirated into the TE biopsy pipette (Research instruments) followed by laser-assisted removal of the target cells from the body of the embryo. All embryos on Day 5, which did not reach the expanding blastocyst stage, were transferred to fresh individual 35 mL drop of blastocyst medium (Sage) and a biopsy was performed on Day 6 if the appropriate stage of development was reached. aCGH was performed only on the material obtained from oocytes/embryos where at least further biopsy was performed on Day 3. All viable blastocysts were cryopreserved by means of vitrification in line with the Italian legislation.
Array CGH and microsatellite analysis
All biopsied samples obtained during the study were washed in sterile phosphate-buffered saline (PBS) solution, in a laminar flow cabinet in order to avoid any contamination of the sample, placed in microcentrifuge tubes containing 2 ml of PBS and then processed for aCGH analysis according to the 24 sure protocol (Blugnome) (Fiorentino et al., 2011) . Visualization and reporting of aneuploidy were performed using Bluefuse Software (BlueGnome) on a per chromosome basis. Only whole chromosome aneuploidies (gains and losses) were scored. The PBs, blastomeres and TE samples with amplification but no diagnosis were determined inconclusive. Structural chromosome defects have been ignored for this analysis. Only whole chromosome aneuploidies (gains and losses) were scored. The PB, blastomere and TE samples with amplification but no diagnosis were determined to be inconclusive. Microsatellite analysis was performed according to the PCR-based PGD protocol described elsewhere .
Segregation pattern analysis and embryo classification data analysis
Following aCGH, each PB, blastomere and TE sample was analyzed for the chromosome copy number and the ploidy status of each of the corresponding oocyte/embryos was predicted in a blinded fashion (Fig. 1) . The per chromosome aneuploidy at each biopsy stage is displayed as gain (G), loss (L) or normal (N) copy number as previously reported by Chromosome analysis on polar bodies and embryos Handyside et al. (2012) with the addition of a follow-up at the blastocyst stage of embryo development (detailed in Fig. 1) . Specifically, (i) the segregation pattern N/N/G/N or N/N/L/N was interpreted as an early mitotic error occurring during the first cleavage divisions leading to mosaicism on Day 3 blastomere analysis but not evident at the blastocyst stage and (ii) the segregation pattern N/N/N/G or N/N/N/L was considered to have originated by a de novo mitotic error early in the development, not detected at the cleavage stage or having arisen during the final stage of preimplantation development during blastocyst formation.
Using the TE biopsy result as a reference, per chromosome copy number concordance of both the PB and the blastomere samples was analyzed. The results were divided into two subsets, either 'consistent' or 'inconsistent', to investigate the diagnostic accuracy of both PB and cleavage-stage PGS strategies. This analysis was based on the 21 sets of complete CCS data including a total of 21 × 23 ¼ 483 chromosome segregation patterns. In this study it was not possible to systematically distinguish between whole chromosomes versus single chromatids copy number variations by interrogation of the aCGH profile of PB1. Thus, MI errors balanced at MII were considered inconsistent when a normal chromosome copy number was observed in the embryo.
Statistical analysis
Continuous data and categorical variables are reported as the mean and percentage frequency, respectively, with 95% confidence interval (CI) and range. Fisher's exact test was used to test the categorical variables.
Diagnostic sensitivity and specificity of PBs and blastomere comprehensive chromosomal analysis against blastocysts molecular karyotype were measured as the proportion of actual positives, which are correctly identified as such, and the proportion of negatives, which are correctly identified. Alpha was set at 0.05.
Results
Nine couples undergoing IVF/ICSI cycles with a median age of 43 years (range 40-45) were included in the study. bodies before and after fertilization was performed along with a single blastomere and TE sample in the resulting embryos. In (B) a diagrammatic representation of the main abnormal copy number segregation patterns resulting from non-disjunction of whole chromosomes and premature predivision of sister chromatids during female meiosis or from mitotic errors during preimplantation development is illustrated. Note that not all possible segregation patterns are represented. G, chromosome copy number gain; L, chromosome copy number loss; N, normal chromosome copy number; PB1, polar body one; PB2, polar body 2. available for analysis. A total of 1932 chromosomes were investigated in 84 array CGH experiments.
Among the chromosomal segregations analyzed, 355 of 483 (73.5%; 95% CI: 69.3 -77.4) had a normal pattern (N/N/N/N). All the blastocysts analyzed were aneuploid and no embryo transfer was performed in this cohort of patients during the course of the trial.
Meiotic chromosomal errors and PBs genetic screening outcome
All the analyzed oocytes had chromosomal abnormalities. One of 21 oocytes contained only meiosis I errors, 10/21 oocytes contained only meiosis II errors with 10/21 containing errors from both meiotic divisions. Twelve oocytes had multiple (more than 2) meiotic aneuploidies with only nine oocytes showing either a single (four oocytes) or double aneuploidy (five oocytes). A significantly higher incidence of copy number errors were detected in the PB2 (69/91) compared with the PB1 (22/91; P , 0.001), with 54 chromatids non-disjunction errors arising at meiosis II (Table I) . Copy number gains and losses were approximately equally represented in both PBs and all chromosomes, with the exception of chromosomes 3 and 4, were involved in female-derived errors. The most frequent aneuploidies were for the smaller and acrocentric chromosomes, with 22, 15, 16 and 17 being the most prevalent. Overall, only 62 out of 78 (79.5%; 95% CI: 68.8 -87.8) abnormal meiotic segregations had copy number gains or losses in either one or both PBs consistent with the aneuploidies observed in the resulting embryos (Table I) . As shown in Table I , the occurrence of chromatid errors in meiosis I with a combined reciprocal gain or loss during the second meiosis mainly explained the inconsistency between PB screening and embryo chromosomes copy number (Table I) . Furthermore, four cases of non-complementary meiotic segregations were observed. One loss in PB1 with normal PB2 and three normal PB1 with losses in PB2 resulted in disomy for the relevant chromosomes in the corresponding embryos observed either in the blastomere or TE samples.
Chromosomal segregation at the cleavage and at the blastocyst stage of development
In this data set it was observed that the number of aneuploidies increased during embryo development to Day 3. A total of 87 copy number gains (37) or losses (50) were recorded on Day 3. However, between the cleavage stage and blastocyst development the aneuploidy frequency was lowered to 81 copy number gains (30) and losses (51). A total of 10 of 21 (47.6%; 95% CI: 25.7 -70.2) embryos had aneuploidies other than those inferred through PB analysis. At the cleavage stage of embryo development, 25 de novo mitotic errors and/or male-derived aneuploidies were recorded, 20 of which were confirmed at the blastocyst stage (80.0%; 95% CI: 59.3 -93.2; Table II), with a skewed ratio towards the losses (18) compared with gains (2). Overall mosaic chromosomal segregations were detected in 6 out of 21 embryos. The five aneuploidies detected only on Day 3, occurred in two single embryos. It is suggested that this may have occurred as a result of mitotic errors during early embryogenesis leading to mosaicism on Day 3. Eleven de novo mitotic aneuploidies were recorded only at the blastocyst stage, with a normal copy number detected in both PBs and blastomeres (Table II) (Table III) . Most of these were the result of a trisomic rescue event. In nine cases a trisomic chromosomes arising from a female meiotic error and confirmed on Day 3 lost a chromosome returning then to a disomic chromosome configuration at the blastocyst stage. In two of these cases where the parental DNA was accessible to STR analysis was performed on blastocyst DNA to test for loss of heterozygosity of trisomic rescued chromosomes. As shown in Fig. 2 , in both cases the trisomies observed in these embryos originated following a chromatid predivision error in MI unbalanced in MII. The microsatellite analysis confirmed a disomic bi-parental configuration with the presence of both chromosomes 13 from the male and female partner in one embryo and a maternal uniparental disomy for chromosome 10 in the other. In the right column is reported the predicted parental origin of the rescued chromosomes. PB1, polar body one; PB2, polar body 2; TE, trophectoderm; G, chromosome copy number gain; L, chromosome copy number loss; N, normal chromosome copy number; ID, Isodisomy; HD, Heterodisomy; BPD, biparental disomy. On the right column is reported the interpretation of the mechanism causing errors based on the chromosomal segregation analysis at cleavage and blastocyst stage of preimplantation embryo development. PB1, polar body one; PB2, polar body 2; TE, trophectoderm; G, chromosome copy number gain; L, chromosome copy number loss; N, normal chromosome copy number.
concordance between PB analysis and blastocyst chromosomal complement was observed only in 8 of 21 (38.1%; 95%; CI: 18.1-61.6) blastocysts.
Discussion
The design of this study has allowed a comprehensive description of the chromosomal segregation events taking place from female meiosis to the blastocyst stage of preimplantation embryo development. It has thus been possible to accurately describe the origin of female-derived meiotic aneuploidies based on the confirmation of PB data in both blastomere and TE samples. This study is not biased by the uncertainty-related PB morphology because of sequential biopsy of the PBs. It has recently been shown that distinction between PB1 and PB2 by morphology alone is only 63% consistent when biopsied simultaneously . Our observations in AMA patients has revealed a pattern of multiple meiotic errors, typically caused by chromatid mal-segregation and arising predominantly at meiosis II as a cause of chromatid nondisjunction. Most of the first meiotic aneuploidies arose as a consequence of premature sister chromatid predivision, leading to balancing events in about half the case during the second meiosis. Notably, all cases of MI errors balanced at MII had a normal mitotic chromosomal segregation until the blastocyst stage, suggesting no downstream effect of premature sister chromatid errors during preimplantation embryo development.
Only one segregation pattern consistent with monosomic oogonia was detected in our data set of IVF AMA patients, suggesting that mitotic errors before entry into meiosis are not a common phenomenon and are not related to a preferential recruitment with increasing reproductive age. This observation is strictly in contrast to the recent theory of the oocyte mosaicism selection model, suggesting that aneuploid oocytes in primordial follicles are preferentially recruited with increased maternal age (Hultén et al., 2010; Obradors et al., 2010) . In line with recent findings obtained in the same study population reported by Handyside et al., 2012 and the molecular evidence reported by Tachibana-Konwalski et al., 2010, it is reasonable to conclude from this study that chromatid errors during both female meiotic divisions are the main pathogenic mechanisms responsible for the female age effect on human aneuploidy. This is likely to be as a result of the prolonged arrest of the chromosomes at the dictyotene stage of the first meiosis.
Furthermore, abnormal meiotic segregation patterns leading to noncomplementary oocyte and PBs chromosome copy number were observed (Fig. 3) . In this data set there are several examples of one PB being nullisomic with the corresponding oocyte normal haploid for the same chromosome. For these cases contamination issues can be confidentially excluded since the other embryo aneuploidies were concordant with the original PB profile. These abnormal segregations may have originated from the compensation of aneuploidy by the sperm or more likely from meiotic chromosome anaphase lag events, leaving behind some chromosomes in the oocyte that would then be degraded to Figure 2 Microsatellite analysis performed on blastocyst DNA to study the parental origin of the trisomic rescued chromosomes. The aCGH ratio plots in (A) and (B) shown the two sets of complete sequential segregation patterns, characterized by a gain in the PB1, a normal copy number in the PB2, a trisomy in the corresponding blastomeres and a final disomy for the same chromosome in the TE. Both chromosomes 13 from the male and female partner were observed in one case (A) and a maternal uniparental disomy for chromosome 10 in the other one (B). mat UPD, maternal uniparental disomy; BPD, biparental disomy.
Chromosome analysis on polar bodies and embryos make the resulting embryo disomic for those chromosomes. Displacements of chromosomes outside the meiotic spindle have been extensively observed by electron microscopy analysis of mature eggs Coticchio et al., 2009) . Even if more data are needed to get an accurate estimation of the clinical meaning of noncomplementary aneuploidies between PBs and corresponding oocyte, this segregation pattern deserves future investigation being at risk of misdiagnosis based on PB screening.
These data also revealed a large proportion of embryos with aneuploidies other than those originating during female meiosis. Most of these were chromosomal loss detected on Day 3 and confirmed on Day 5/6. Even if it was not possible to distinguish between male or mitotic origin, these data are well matched with both the increased level of sperm monosomies compared with trisomy observed in human cleavage stage embryos (Rabinowitz et al., 2012) and with previous data showing anaphase lag (AL) as the main mitotic mechanism causing error during preimplantation development (Delhanty, 2005) .
Interestingly, as high as 20% of female-derived aneuploidies detected on PBs and confirmed on Day 3 were not present at the blastocyst stage. As expected, all these events were mostly the result of a trisomic rescue because both non-dijunction and AL contribute to reduce the hyperploidy. If loss of one of the three chromosomes from a trisomy occurs randomly, then uniparental disomy (UPD) would be expected in the derivative diploid lineage 1/3 of the time. By microsatellite analysis we have been able to report the first direct observation of a biparental disomy rescue of a meiotic trisomy between the cleavage and the blastocyst stage of preimplantation development. For another chromosome a maternal UPD was confirmed. Unfortunately, it was not possible to assess whether the corrected chromosomes were in a mosaic configuration or constitutional within the embryo. In humans, constitutional and mosaic UPD are thought to mainly originate as a consequence of trisomic zygote rescue (Purvis-Smith et al., 1992; Kotzot, 1999; Robinson, 2000) and are involved in clinical conditions by producing either aberrant patterns of imprinting and also homozygosity for recessive mutations in the case of isodisomy. Whole chromosome UPDs have been also extensively detected in products of conception and during prenatal testing (Engel, 1999; Fritz et al., 2001; Tsukishiro, 2005) , with a preponderance of maternal versus paternal origin. Due to the high correction rate observed here and considering the dramatic increase in aneuploidies with female age, maternal UPD may be particularly significant during PGS cycles of patients with AMA and deserves further investigation.
From a clinical perspective, important information can be drawn out of this data set. Primarily, testing the first PB alone is definitively not effective as a screening approach for oocyte aneuploidies as previously reported (Sher et al., 2007) . According to our results the screening of PB1 alone should not be offered to patients when balancing events and new errors during the second meiosis cannot be concomitantly assessed by the analysis of PB2. With the addition of the PB2 data, more accurate information inferring oocyte chromosome copy number can be obtained. However, concerns related to whether the accuracy achievable using PB screening is good enough to improve the IVF clinical outcome still remains (Angell, 1994; Scriven et al., 2012) . This study showed that the accuracy of PB approach was singificantly lower compared to the cleavage stage single blastomere analysis when results were correlated with blastocyst karyotype. These findings can be manly explained by (i) the high false-positive rate obtained by PB approach because of the inability to consistently identify the MI errors balanced at MII (Fig. 3); (ii) the considerable proportion of female meiotic aneuploidy correction at the blastocyst stage and (iii) the high rate of male and/or mitoticderived aneuploidies observed in the embryo. These intrinsic limitations of PB analysis may result in one case discarding viable embryos, while in the other transferring abnormal ones. It should be noted that in our data set all the embryos with a correction event remained abnormal due to the presence of additional aneuploidies. Even if our study was based on a per-chromosome analysis in a severe poor prognosis population of patients and no euploid embryos have been obtained at the blastocyst stage, there is no reason to assume that the limitation of PB screening observed here is unique to abnormal oocytes and embryos of AMA. Indeed, it has been recently demonstrated that a euploid embryo derived from an oocyte with reciprocal aneuploid PBs due to a chromatid predivision error in MI followed by a balancing segregation at MII was capable of producing a chromosomally normal child (Scott et al., 2012b) . A similar phenomenon was also reported in the preclinical study evaluating the utility of PB aCGH strategy conducted by the European Society of Human Reproduction and Embryology PGS Task Force. In this independent investigation 4% of the zygotes were shown to be euploid despite aneuploidies were predicted based on PB analysis (Geraedts et al., 2011) .
Another major problem related to PB biopsy is the paucity of material that is available. In our hands as well as in the practice of other qualified centers, not less than 1 out of 10 oocytes tested remain without a conclusive diagnosis because of failure of diagnosis of at least one of the two PBs (Geraedts et al., 2011) . If preimplantation screening aims to improve IVF outcomes, it is crucial that results are obtained from all embryos tested. Moreover, the economic and logistic issues cannot be disregarded, with PB screening being the most time-consuming and least cost-effective approach among the PGS strategies. A further advantage of postponing the time of biopsy is to not affect the blastocyst development rate by extra-manipulations prior to blastocyst development (Scott et al., 2012a) .
All this evidence points to postponing the time of biopsy as late as possible in the preimplantation window, possibly with the use of technologies able to determine not only the chromosomal count in a cell but also parental origin of each chromosome, i.e. whether a disomy is euploid versus UPD.
To conclude, these new findings provide critical information to improve the design of clinical PGS strategies as well as the genetic preconception counseling of IVF patients.
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